Bristol Myers Exits Cellares Partnership, Triggering Corporate Restructuring

Pharmaceutical giant Bristol Myers Squibb has terminated its development pact with cell therapy startup Cellares, forcing the smaller company to initiate a major corporate restructuring plan.